Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Rating) saw a significant decline in short interest in November. As of November 30th, there was short interest totalling 1,600 shares, a decline of 69.2% from the November 15th total of 5,200 shares. Based on an average trading volume of 5,300 shares, the short-interest ratio is currently 0.3 days.
Algernon Pharmaceuticals Stock Down 4.6 %
Shares of OTCMKTS:AGNPF opened at $1.87 on Wednesday. The company has a 50 day moving average of $2.12 and a 200 day moving average of $2.98. Algernon Pharmaceuticals has a 12 month low of $1.60 and a 12 month high of $9.28.
Get Algernon Pharmaceuticals alerts:Algernon Pharmaceuticals Company Profile
(Get Rating)
Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia.Further Reading
- Get a free copy of the StockNews.com research report on Algernon Pharmaceuticals (AGNPF)
- We Are the Champions: 3 Dividend Growers Wall Street Loves
- Harpoon Therapeutics Remains Volatile After Promising News
- Will Nordstrom Stock be the Grinch This Year?
- What is Market Structure in Trading?
- Institutional Selling Is No Headwind For Nike
Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.